Epidural Steroid Injections Under Scrutiny
FDA warns against rare but serious pain management complications.
Published: April 30, 2014
Pain management practitioners have been injecting corticosteroids into the epidural space of the spine for decades to reduce swelling and inflammation, but this practice has on occasion caused serious neurological complications, including vision loss, stroke, paralysis and even death, warns the Food and Drug Administration.
In a recent safety warning, the agency notes that the effectiveness and safety of treating neck and back pain through epidurally administered hydrocortisone, dexamethasone, methylprednisolone or other corticosteroids has not been established, and that it has not approved them for this use.
The FDA is requiring the drugs' labeling to include descriptions of these risks. The agency has convened panels of experts to recommend injection techniques that could prevent harm and to discuss whether further examination and action on the risks of epidural corticosteroid injection is necessary.
© Copyright Herrin Publishing Partners LP. REPRODUCTION OF THIS COPYRIGHTED CONTENT IS STRICTLY PROHIBITED. We encourage LINKING to this content; view our linking policy here.
Also in the News...
Surgeon Operated on Wrong Part of Brain
Widow Sues Olympus and Custom Ultrasonics Over Husband's Superbug Death
Surgeons Reach Peak Performance Between 35 and 50 Years Old
Results From Head-to-Head Comparison of Exparel and Conventional Bupivacaine
Forbes: Punitive Ban on Physician-Owned Hospitals Imposed by the Affordable Care Act Has to Go
'Post-Hospital Syndrome' Is a Risk Factor in Elective Surgery
FDA Approval of Sugammadex Appears Imminent